eISSN: 2377-4304
Submit manuscript...
Commentary Volume 11 Issue 2
Proposed use of shared decision making (SDM) to facilitate informed patient choice in the management of cholestasis of pregnancy (ICP)
Cassandra E Henderson, Shadi Rezai, Richard A Giovane
Garden OB/GYN, Mercy Medical Center, USA
Valley Community Healthcare, 6801 Coldwater Canyon Avenue, USA
Regional Medical Center of Central Alabama, USA
Received: March 02, 2020 | Published: April 15, 2020
Citation: Henderson CE, Rezai S, Proposed use of shared decision making (SDM) to facilitate informed patient choice in the management of cholestasis of pregnancy (ICP). Obstet Gynecol Int J. 2020;11(2):117-120. DOI: 10.15406/ogij.2020.11.00497
Abstract
Despite a paucity of data that intrahepatic cholestasis of pregnancy (ICP) is a risk for unexplained term fetal demise, active management to achieve delivery between 36 0/7 and 37 0/7 weeks remains standard clinical practice. This practice continues despite conflicting evidence associating ICP with increased stillbirth risk, disregarding the simultaneous presence of voluminous data attesting to the perinatal and pediatric hazards associated with late preterm and early-term deliveries. This clinical risk correlation between possible antenatal death versus the potential long-term consequences for iatrogenic late preterm or early term infant born from an ICP affected pregnancy warrants inclusion of shared decision making to elicit the patient’s values and preferences during the ICP management option informed consent process.
Keywords: Bile acid, Early term birth, Full-term birth, Intrahepatic cholestasis of pregnancy, Patient decision aid, Shared decision making
©2020 Henderson, et al. This is an open access article distributed under the terms of the, which permits unrestricted use, distribution, and build upon your work non-commercially.